GSK-101

N/A

Report date: 2023/08/22 17:31:21
NME

Base Information

Drug NameGSK-101
Drug Alias NamePol theta helicase inhibitorPOLQ inhibitor(Ideaya Biosciences Inc)DNA polymerase θ inhibitor(Ideaya Biosciences Inc)DNA polymerase theta helicase inhibitor (Ideaya Biosciences Inc)GSK-101 +[7] 
ClassificationSmall molecules
Mechanisms of ActionDNA-directed DNA polymerase inhibitorsDNA polymerase theta inhibitors
TargetsDNA-directed DNA polymeraseDNA polymerase theta
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIdeaya Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcIdeaya Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A